CLOV - Clover Health Investments Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CLOV is currently covered by 3 analysts with an average price target of $4.08. This is a potential upside of $0.18 (-3.32%) from yesterday's end of day stock price of $4.22.

Clover Health Investments Corp's activity chart (see below) currently has 30 price targets and 32 ratings on display. The stock rating distribution of CLOV is 44.44% HOLD and 55.56% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 88.35% with an average time for these price targets to be met of 116.31 days.

Highest price target for CLOV is $5.5, Lowest price target is $2.5, average price target is $4.08.

Most recent stock forecast was given by JONATHAN YONG from UBS on 06-Aug-2026. First documented stock forecast 01-Feb-2021.

Best performing analysts who are covering CLOV - Clover Health Investments Corp:

Kevin Fischbeck Ralph Giacobbe Jailendra Singh Richard Close Jason Cassorla Jonathan Yong Whit Mayo

Currently out of the existing stock ratings of CLOV, 4 are a HOLD (44.44%), 5 are a BUY (55.56%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 24-Feb-2025

$5

$0.4 (8.70%)

$4.75

Buy Since 03-Feb-2022

$5.5

$0.9 (19.57%)

$4.2

Hold Since 19-Jan-2022

$2.5

$-2.91 (-53.79%)

$3

Hold Since 07-Oct-2024

$3

$-2.41 (-44.55%)

$4.5

Hold Since 10-Jan-2022

$1.8

$-0.13 (-6.74%)

$3.5

Show more analysts

Please expand the browser size to see the chart

What is CLOV (Clover Health Investments Corp) average time for price targets to be met?

On average it took 116.31 days on average for the stock forecasts to be realized with a an average price target met ratio 88.35

Which analyst has the current highest performing score on CLOV (Clover Health Investments Corp) with a proven track record?

KEVIN FISCHBECK

Which analyst has the most public recommendations on CLOV (Clover Health Investments Corp)?

Kevin Fischbeck works at BAML and has 26 price targets and 16 ratings on CLOV

Which analyst is the currently most bullish on CLOV (Clover Health Investments Corp)?

Kevin Fischbeck with highest potential upside - $8.07

Which analyst is the currently most reserved on CLOV (Clover Health Investments Corp)?

Whit Mayo with lowest potential downside - -$2.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?